Background COVID-19 is associated with androgenetic alopecia (AGA), telogen effluvium
(TE), and alopecia areata (AA). No studies have analyzed the aggregate data to date …

This systematic review focuses on the clinical features, physical examination findings,
outcomes, and underlying pathology of acute telogen effluvium (TE), a type of diffuse hair …

Background The cutaneous manifestations of COVID-19 may be useful disease markers and
prognostic indicators. Recently, postinfectious telogen effluvium and trichodynia have also …

COVID‐19 is a febrile, infectious illness that has previously been associated with telogen
effluvium (TE). However, to date, no study has been conducted to determine the incidence of …

Background COVID‐19 is a highly contagious respiratory tract infection caused by severe
acute respiratory syndrome coronavirus 2. COVID‐19 outbreak, which caused thousands of …

The diffusion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inducing
coronavirus disease 2019 (COVID-19) has increased the incidence of several …

COVID-19 is a concerning global pandemic. Common manifestations are fever and
respiratory symptoms. In addition, recent studies reported dermatological manifestations as …

While popular belief harbors little doubt that perceived stress can cause hair loss and
premature graying, the scientific evidence for this is arguably much thinner. Here, we …

Post-SARS-CoV-2 telogen effluvium has been described in case reports of COVID-19
patients. We evaluated the prevalence of post-SARS-CoV-2 telogen effluvium in patients …

Objective While there are literature reporting increased incidence of hair loss in COVID‐19
patients, insufficient evidence exists on the topic to date. This review aims to identify the …